Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.
Kemmotsu N, Ninomiya K, Kunimasa K, Ishino T, Nagasaki J, Otani Y, Michiue H, Ichihara E, Ohashi K, Inoue T, Tamiya M, Sakai K, Ueda Y, Dansako H, Nishio K, Kiura K, Date I, Togashi Y.
Kemmotsu N, et al. Among authors: kunimasa k.
Int J Cancer. 2024 Jan 1;154(1):169-179. doi: 10.1002/ijc.34700. Epub 2023 Aug 23.
Int J Cancer. 2024.
PMID: 37611176